reference/1882383

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/1882383

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Journal Article\|Multicenter Study
endingPage	1367
issn	1476-5551 0887-6924
issueIdentifier	6
pageRange	1363-1367
publicationName	Leukemia
startingPage	1363
bibliographicCitation	Krönke J, Kuchenbauer F, Kull M, Teleanu V, Bullinger L, Bunjes D, Greiner A, Kolmus S, Köpff S, Schreder M, Mügge LO, Straka C, Engelhardt M, Döhner H, Einsele H, Bassermann F, Bargou R, Knop S, Langer C. IKZF1 expression is a prognostic marker in newly diagnosed standard-risk multiple myeloma treated with lenalidomide and intensive chemotherapy: a study of the German Myeloma Study Group (DSMM). Leukemia. 2017 Jun;31(6):1363–7. doi: 10.1038/leu.2016.384. PMID: 28017969.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5c8dfa5a0e9b9d5e2d189d9397da1950 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d4db055bf9b1804e6b669a700ddf223b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e50642ea8f921b9429082c8352514014 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_67bf6c74e6156bf948472f4f7dbbbd74 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_502cca71ea920a6796dc496ce5a35832 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ee1bde9d80ba4d67810021d581999695 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1d37c9e82983ae7006f8c01303c258f3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_12b9f50d126694217801d0189f182e60 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3e8f43e4759b9c30c60fb2d50c9fe614 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e9cd41663a8daee1ef8dff8f1db720e7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8318d0fd8526cb65d02a68d6e7668117 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1fa1a9e9d3404bb33733b86ebb1f21ec http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_958aab9136740fb4b9e47b357ced918a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2e3fdd82e0dd77e939433a502ee20daf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3b70abc8ad90c2d080cecb1600cd048d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d25ea999e2ba79af957f5a932b6c15de http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a446b75c2f82f75f5133eae4e17eeaad http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c149b2482ca12aeb9508c8150b051ca0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_23c24b2ca82ba503d914001395c6931e
date	2016-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1038/leu.2016.384 https://pubmed.ncbi.nlm.nih.gov/28017969
isPartOf	https://portal.issn.org/resource/ISSN/1476-5551 https://portal.issn.org/resource/ISSN/0887-6924 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5536
language	English
source	https://scigraph.springernature.com/ https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	IKZF1 expression is a prognostic marker in newly diagnosed standard-risk multiple myeloma treated with lenalidomide and intensive chemotherapy: a study of the German Myeloma Study Group (DSMM)
discusses	http://id.nlm.nih.gov/mesh/M0006784 http://id.nlm.nih.gov/mesh/M0021267 http://id.nlm.nih.gov/mesh/M0006099 http://id.nlm.nih.gov/mesh/M0208676 http://id.nlm.nih.gov/mesh/M0450844 http://id.nlm.nih.gov/mesh/M0022149 http://id.nlm.nih.gov/mesh/M0479831
hasSubjectTerm	http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112 http://purl.org/au-research/vocabulary/anzsrc-for/2008/11
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_6c0a79e077ab9a9c014c60646b1c1b6f http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8561 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_6be0c5d46f46c0e756100c24a60c0490 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8530 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_dfe01d8e8dd718dcb672a1c021867203 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_beddbd510e1c321669ee620d695f3965 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_2e4906e8c6048d6263e53edaeb34ea09 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID216326

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID682 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID51185 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID10320

Total number of triples: 59.